[go: up one dir, main page]

SG133601A1 - Use of gaboxadol for treating insomnia - Google Patents

Use of gaboxadol for treating insomnia

Info

Publication number
SG133601A1
SG133601A1 SG200704528-9A SG2007045289A SG133601A1 SG 133601 A1 SG133601 A1 SG 133601A1 SG 2007045289 A SG2007045289 A SG 2007045289A SG 133601 A1 SG133601 A1 SG 133601A1
Authority
SG
Singapore
Prior art keywords
gaboxadol
treating insomnia
insomnia
treating
Prior art date
Application number
SG200704528-9A
Other languages
English (en)
Inventor
Bjarke Ebert
Jonas Lundahl
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG133601(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SG133601A1 publication Critical patent/SG133601A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/423Oxazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
SG200704528-9A 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia SG133601A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200301877 2003-12-18

Publications (1)

Publication Number Publication Date
SG133601A1 true SG133601A1 (en) 2007-07-30

Family

ID=34684447

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200704528-9A SG133601A1 (en) 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia

Country Status (17)

Country Link
EP (1) EP1720547A1 (es)
JP (1) JP2007515415A (es)
KR (1) KR20060103335A (es)
CN (1) CN1893942A (es)
AR (1) AR047154A1 (es)
AU (1) AU2004298313A1 (es)
BR (1) BRPI0415893A (es)
CA (1) CA2550610A1 (es)
EA (1) EA200600989A1 (es)
IL (1) IL176239A0 (es)
IS (1) IS8390A (es)
MX (1) MXPA06006685A (es)
NO (1) NO20063320L (es)
SG (1) SG133601A1 (es)
TW (1) TW200528098A (es)
WO (1) WO2005058313A1 (es)
ZA (1) ZA200602762B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
US20080262029A1 (en) * 2005-04-29 2008-10-23 H. Lundbeck A/S Acid and Base Salt Forms of Gaboxadol
IL256912B2 (en) 2015-07-17 2024-01-01 Ovid Therapeutics Inc Methods of treating developmental disorders with gaboxadol
AU2018331326A1 (en) * 2017-09-12 2020-03-19 Ovid Therapeutics Inc. Use of gaboxadol in the treatment of narcolepsy
EP3833351A4 (en) 2018-09-20 2021-10-13 Ovid Therapeutics Inc. USE OF GABOXADOL FOR THE TREATMENT OF GILLES DE LA TOURETTE SYNDROME, TICS AND STATTING
US11690829B2 (en) 2018-12-17 2023-07-04 Ovid Therapeutics Inc. Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
MX2022007715A (es) 2019-12-18 2022-07-19 Ovid Therapeutics Inc Gaboxadol para el tratamiento terapeutico del sindrome de delecion 1p36.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
UA80092C2 (en) * 2001-05-21 2007-08-27 Lundbeck & Co As H Granular preparations of gaboxadol, process for the preparation thereof and pharmaceutical composition

Also Published As

Publication number Publication date
CN1893942A (zh) 2007-01-10
IL176239A0 (en) 2006-10-05
WO2005058313A1 (en) 2005-06-30
NO20063320L (no) 2006-07-18
AR047154A1 (es) 2006-01-11
AU2004298313A1 (en) 2005-06-30
CA2550610A1 (en) 2005-06-30
MXPA06006685A (es) 2006-08-23
JP2007515415A (ja) 2007-06-14
KR20060103335A (ko) 2006-09-28
ZA200602762B (en) 2007-06-27
BRPI0415893A (pt) 2007-01-09
IS8390A (is) 2006-03-30
EP1720547A1 (en) 2006-11-15
TW200528098A (en) 2005-09-01
EA200600989A1 (ru) 2006-10-27

Similar Documents

Publication Publication Date Title
GB0325192D0 (en) Method of use
GB0308731D0 (en) Method of radiotherapy
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
GB0324761D0 (en) Use of compounds in therapy
EP1613266A4 (en) METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF
EP1677794A4 (en) METHODS OF TREATING DISORDERS
IL175351A0 (en) Methods of treating asthma
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
EP1653982A4 (en) TREATING BAD ODOR
GB0302572D0 (en) Method of treatment
SG133601A1 (en) Use of gaboxadol for treating insomnia
GB0306309D0 (en) Method of treatment
GB0426196D0 (en) Methods of treatment
GB0217493D0 (en) Novel methods of treatment
GB0208897D0 (en) New method of treatment
GB0329416D0 (en) Treatment of cancer
GB0221712D0 (en) Methods of treatment
GB0327975D0 (en) Methods of treatment
ZA200606071B (en) Methods of treating asthma
GB2398069B (en) Treatment of ferrous waste
GB2392617A8 (en) Surface treatment of SARS-infected lungs
GB0322921D0 (en) Methods of treatment
GB0213198D0 (en) Method of treatment
GB0313801D0 (en) Novel methods of treatment
GB0210210D0 (en) Treatment of hydrocarbons